A Phase 2, Randomized, Double-blind, Placebo- and Active-controlled, Parallel-group, Multicenter Study Evaluating the Analgesic Efficacy and Safety of V116517 in Subjects With Moderate to Severe Chronic Pain Due to Postherpetic Neuralgia (PHN)
Phase of Trial: Phase II
Latest Information Update: 12 Jun 2014
At a glance
- Drugs V 116517 (Primary) ; Pregabalin
- Indications Neuropathic pain; Postherpetic neuralgia
- Focus Therapeutic Use
- Sponsors Purdue Pharma
- 09 May 2014 According to the ClinicalTrials.gov record, status changed from active, no longer recruiting to completed.
- 27 Jan 2014 Status changed from recruiting to active, no longer recruiting according to ClinicalTrials.gov record.
- 25 Sep 2012 New trial record